{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:19:28Z","timestamp":1791566368658,"version":"4.3.4"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The development of tools to monitor the right ventricle in pulmonary arterial hypertension (PAH) is of clinical importance. PAH is associated with pathologic expression of the transcription factor hypoxia-inducible factor (HIF)-1\u03b1, which induces glycolytic metabolism and mobilization of proangiogenic progenitor (CD34+CD133+) cells. We hypothesized that PAH cardiac myocytes have a HIF-related switch to glycolytic metabolism that can be detected with fasting 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography (FDG-PET) and that glucose uptake is informative for cardiac function.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Six healthy control subjects and 14 patients with PAH underwent fasting FDG-PET and echocardiogram. Blood CD34+CD133+ cells and erythropoietin were measured as indicators of HIF activation. Twelve subjects in the PAH cohort underwent repeat studies 1 year later to determine if changes in FDG uptake were related to changes in echocardiographic parameters or to measures of HIF activation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and Results<\/jats:title>\n                    <jats:p>FDG uptake in the right ventricle was higher in patients with PAH than in healthy control subjects and correlated with echocardiographic measures of cardiac dysfunction and circulating CD34+CD133+ cells but not erythropoietin. Among patients with PAH, FDG uptake was lower in those receiving \u03b2-adrenergic receptor blockers. Changes in FDG uptake over time were related to changes in echocardiographic parameters and CD34+CD133+ cell numbers. Immunohistochemistry of explanted PAH hearts of patients undergoing transplantation revealed that HIF-1\u03b1 was present in myocyte nuclei but was weakly detectable in control hearts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>PAH hearts have pathologic glycolytic metabolism that is quantitatively related to cardiac dysfunction over time, suggesting that metabolic imaging may be useful in therapeutic monitoring of patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1513\/annalsats.201206-029oc","type":"journal-article","created":{"date-parts":[[2014,2,14]],"date-time":"2014-02-14T10:04:03Z","timestamp":1392372243000},"page":"1-9","source":"Crossref","is-referenced-by-count":112,"title":["Fasting 2-Deoxy-2-[18F]fluoro-\n                    <scp>d<\/scp>\n                    -glucose Positron Emission Tomography to Detect Metabolic Changes in Pulmonary Arterial Hypertension Hearts over 1 Year"],"prefix":"10.1093","volume":"10","author":[{"given":"Erika L.","family":"Lundgrin","sequence":"first","affiliation":[{"name":"Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret M.","family":"Park","sequence":"additional","affiliation":[{"name":"Heart & Vascular Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Sharp","sequence":"additional","affiliation":[{"name":"Department of Pathobiology, Lerner Research Institute, Cleveland, Ohio; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.H. Wilson","family":"Tang","sequence":"additional","affiliation":[{"name":"Heart & Vascular Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Thomas","sequence":"additional","affiliation":[{"name":"Heart & Vascular Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kewal","family":"Asosingh","sequence":"additional","affiliation":[{"name":"Department of Pathobiology, Lerner Research Institute, Cleveland, Ohio; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzy A.","family":"Comhair","sequence":"additional","affiliation":[{"name":"Department of Pathobiology, Lerner Research Institute, Cleveland, Ohio; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank P.","family":"DiFilippo","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald R.","family":"Neumann","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Davis","sequence":"additional","affiliation":[{"name":"Program in Translational Lung Research, University of Colorado School of Medicine, Aurora, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian B.","family":"Graham","sequence":"additional","affiliation":[{"name":"Program in Translational Lung Research, University of Colorado School of Medicine, Aurora, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rubin M.","family":"Tuder","sequence":"additional","affiliation":[{"name":"Program in Translational Lung Research, University of Colorado School of Medicine, Aurora, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iva","family":"Dostanic","sequence":"additional","affiliation":[{"name":"Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serpil C.","family":"Erzurum","sequence":"additional","affiliation":[{"name":"Department of Pathobiology, Lerner Research Institute, Cleveland, Ohio; and"},{"name":"Respiratory Institute, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,2,1]]},"reference":[{"key":"2026012303582749000_bib1","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1242\/dmm.003616","article-title":"Idiopathic pulmonary arterial hypertension","volume":"3","author":"Firth","year":"2010","journal-title":"Dis Model Mech"},{"key":"2026012303582749000_bib2","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1161\/CIRCULATIONAHA.109.911818","article-title":"Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era","volume":"122","author":"Humbert","year":"2010","journal-title":"Circulation"},{"key":"2026012303582749000_bib3","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.jacc.2007.07.029","article-title":"Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency","volume":"50","author":"Toblli","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2026012303582749000_bib4","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1183\/09031936.00070209","article-title":"Prognostic factors of acute heart failure in patients with pulmonary arterial hypertension","volume":"35","author":"Sztrymf","year":"2010","journal-title":"Eur Respir J"},{"key":"2026012303582749000_bib5","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1172\/JCI112820","article-title":"Myocardial metabolism of free fatty acids: studies with 14C-labeled substrates in humans","volume":"79","author":"WXisneski","year":"1987","journal-title":"J Clin Invest"},{"key":"2026012303582749000_bib6","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/RLU.0b013e3182177389","article-title":"Increased right ventricular glucose metabolism in patients with pulmonary arterial hypertension","volume":"36","author":"Can","year":"2011","journal-title":"Clin Nucl Med"},{"key":"2026012303582749000_bib7","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/j.jacc.2005.02.065","article-title":"Increased [18F]fluorodeoxyglucose accumulation in right ventricular free wall in patients with pulmonary hypertension and the effect of epoprostenol","volume":"45","author":"Oikawa","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2026012303582749000_bib8","doi-asserted-by":"crossref","first-page":"448","DOI":"10.4103\/2045-8932.93543","article-title":"(18)FDG PET imaging can quantify increased cellular metabolism in pulmonary arterial hypertension: a proof-of-principle study","volume":"1","author":"Hagan","year":"2011","journal-title":"Pulm Circ"},{"key":"2026012303582749000_bib9","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1056\/NEJMra1011165","article-title":"Oxygen sensing, homeostasis, and disease","volume":"365","author":"Semenza","year":"2011","journal-title":"N Engl J Med"},{"key":"2026012303582749000_bib10","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1182\/blood-2010-09-306357","article-title":"Hypoxia-inducible factors in human pulmonary arterial hypertension: a link to the intrinsic myeloid abnormalities","volume":"117","author":"Farha","year":"2011","journal-title":"Blood"},{"key":"2026012303582749000_bib11","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1073\/pnas.0605080104","article-title":"Alterations of cellular bioenergetics in pulmonary artery endothelial cells","volume":"104","author":"Xu","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026012303582749000_bib12","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.2353\/ajpath.2010.090832","article-title":"Hypoxia inducible-factor1alpha regulates the metabolic shift of pulmonary hypertensive endothelial cells","volume":"176","author":"Fijalkowska","year":"2010","journal-title":"Am J Pathol"},{"key":"2026012303582749000_bib13","first-page":"A3450","article-title":"Glycolytic metabolism in hearts of pulmonary arterial hypertension patients [abstract]","volume":"185","author":"Lundgrin","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012303582749000_bib14","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.echo.2010.05.010","article-title":"Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography","volume":"23","author":"Rudski","year":"2010","journal-title":"J Am Soc Echocardiogr"},{"key":"2026012303582749000_bib15","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S0735-1097(85)80433-2","article-title":"An echocardiographic index for separation of right ventricular volume and pressure overload","volume":"5","author":"Ryan","year":"1985","journal-title":"J Am Coll Cardiol"},{"key":"2026012303582749000_bib16","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/0735-1097(92)90056-S","article-title":"Doppler echocardiographic demonstration of the differential effects of right ventricular pressure and volume overload on left ventricular geometry and filling","volume":"19","author":"Louie","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"2026012303582749000_bib17","doi-asserted-by":"crossref","first-page":"14S","DOI":"10.1378\/chest.126.1_suppl.14S","article-title":"Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines","volume":"126","author":"McGoon","year":"2004","journal-title":"Chest"},{"key":"2026012303582749000_bib18","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","article-title":"ATS statement: guidelines for the six-minute walk test","volume":"166","author":"American Thoracic Society","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012303582749000_bib19","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1093\/eurheartj\/ehl477","article-title":"Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension","volume":"28","author":"van Wolferen","year":"2007","journal-title":"Eur Heart J"},{"key":"2026012303582749000_bib20","doi-asserted-by":"crossref","first-page":"615","DOI":"10.2353\/ajpath.2008.070705","article-title":"Circulating angiogenic precursors in idiopathic pulmonary arterial hypertension","volume":"172","author":"Asosingh","year":"2008","journal-title":"Am J Pathol"},{"key":"2026012303582749000_bib21","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1161\/CIRCIMAGING.109.905984","article-title":"Relation between right ventricular function and increased right ventricular [18F]fluorodeoxyglucose accumulation in patients with heart failure","volume":"4","author":"Mielniczuk","year":"2011","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026012303582749000_bib22","first-page":"25","article-title":"Different mechanisms for changes in glucose uptake of the right and left ventricular myocardium in pulmonary hypertension","volume":"46","author":"Kluge","year":"2005","journal-title":"J Nucl Med"},{"key":"2026012303582749000_bib23","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1161\/CIRCHEARTFAILURE.111.962381","article-title":"Right ventricular failure in idiopathic pulmonary arterial hypertension is associated with inefficient myocardial oxygen utilization","volume":"4","author":"Wong","year":"2011","journal-title":"Circ Heart Fail"},{"key":"2026012303582749000_bib24","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1161\/CIRCIMAGING.110.963207","article-title":"PET imaging may provide a novel biomarker and understanding of right ventricular dysfunction in patients with idiopathic pulmonary arterial hypertension","volume":"4","author":"Bokhari","year":"2011","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026012303582749000_bib25","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1164\/rccm.201108-1562OC","article-title":"Lung 18F-fluorodeoxyglucose positron emission tomography for diagnosis and monitoring of pulmonary arterial hypertension","volume":"185","author":"Marsboom","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012303582749000_bib26","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1161\/CIRCULATIONAHA.109.883843","article-title":"Chronic pulmonary artery pressure elevation is insufficient to explain right heart failure","volume":"120","author":"Bogaard","year":"2009","journal-title":"Circulation"},{"key":"2026012303582749000_bib27","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.amjcard.2012.01.366","article-title":"Comparison of baseline predictors of prognosis in pulmonary arterial hypertension in patients surviving &lt;2 years and those surviving &gt;5 years after baseline right-sided cardiac catheterization","volume":"109","author":"Batal","year":"2012","journal-title":"Am J Cardiol"},{"key":"2026012303582749000_bib28","doi-asserted-by":"crossref","first-page":"H570","DOI":"10.1152\/ajpheart.01324.2007","article-title":"Mitochondrial metabolism, redox signaling, and fusion: a mitochondria-ROS-HIF-1alpha-Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancer","volume":"294","author":"Archer","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2026012303582749000_bib29","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1161\/CIRCULATIONAHA.105.609008","article-title":"An abnormal mitochondrial-hypoxia inducible factor-1alpha-Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats: similarities to human pulmonary arterial hypertension","volume":"113","author":"Bonnet","year":"2006","journal-title":"Circulation"},{"key":"2026012303582749000_bib30","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1161\/CIRCULATIONAHA.109.916098","article-title":"Epigenetic attenuation of mitochondrial superoxide dismutase 2 in pulmonary arterial hypertension: a basis for excessive cell proliferation and a new therapeutic target","volume":"121","author":"Archer","year":"2010","journal-title":"Circulation"},{"key":"2026012303582749000_bib31","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1084\/jem.20101812","article-title":"Role for miR-204 in human pulmonary arterial hypertension","volume":"208","author":"Courboulin","year":"2011","journal-title":"J Exp Med"},{"key":"2026012303582749000_bib32","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1161\/ATVBAHA.109.202028","article-title":"Dynamic changes in lung microRNA profiles during the development of pulmonary hypertension due to chronic hypoxia and monocrotaline","volume":"30","author":"Caruso","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026012303582749000_bib33","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1164\/rccm.201106-1130OC","article-title":"Altered microRNA processing in heritable pulmonary arterial hypertension: an important role for Smad-8","volume":"184","author":"Drake","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012303582749000_bib34","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1161\/CIRCRESAHA.108.193102","article-title":"Downregulation of miR-199a derepresses hypoxia-inducible factor-1alpha and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes","volume":"104","author":"Rane","year":"2009","journal-title":"Circ Res"},{"key":"2026012303582749000_bib35","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1172\/JCI42980","article-title":"Hypoxia-induced microRNA-424 expression in human endothelial cells regulates HIF-\u03b1 isoforms and promotes angiogenesis","volume":"120","author":"Ghosh","year":"2010","journal-title":"J Clin Invest"},{"key":"2026012303582749000_bib36","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/jcp.22126","article-title":"miR-20b modulates VEGF expression by targeting HIF-1 alpha and STAT3 in MCF-7 breast cancer cells","volume":"224","author":"Cascio","year":"2010","journal-title":"J Cell Physiol"},{"key":"2026012303582749000_bib37","doi-asserted-by":"crossref","first-page":"5540","DOI":"10.1158\/0008-5472.CAN-07-6460","article-title":"Identification of hypoxia-inducible factor-1 alpha as a novel target for miR-17\u201392 microRNA cluster","volume":"68","author":"Taguchi","year":"2008","journal-title":"Cancer Res"},{"key":"2026012303582749000_bib38","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1158\/0008-5472.CAN-09-2291","article-title":"miR-31 ablates expression of the HIF regulatory factor FIH to activate the HIF pathway in head and neck carcinoma","volume":"70","author":"Liu","year":"2010","journal-title":"Cancer Res"},{"key":"2026012303582749000_bib39","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1158\/0008-5472.CAN-09-2448","article-title":"MicroRNA-519c suppresses hypoxia-inducible factor-1 alpha expression and tumor angiogenesis","volume":"70","author":"Cha","year":"2010","journal-title":"Cancer Res"},{"key":"2026012303582749000_bib40","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1161\/CIRCHEARTFAILURE.111.961474","article-title":"Impaired mitochondrial biogenesis precedes heart failure in right ventricular hypertrophy in congenital heart disease","volume":"4","author":"Karamanlidis","year":"2011","journal-title":"Circ Heart Fail"},{"key":"2026012303582749000_bib41","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1172\/JCI5912","article-title":"Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1alpha","volume":"103","author":"Yu","year":"1999","journal-title":"J Clin Invest"},{"key":"2026012303582749000_bib42","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1128\/MCB.01580-07","article-title":"Hypoxia-inducible factor-dependent degeneration, failure, and malignant transformation of the heart in the absence of the von Hippel-Lindau protein","volume":"28","author":"Lei","year":"2008","journal-title":"Mol Cell Biol"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/10\/1\/1\/66486348\/annalsats_10_1_1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/10\/1\/1\/66486348\/annalsats_10_1_1.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T08:59:23Z","timestamp":1769158763000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/10\/1\/1\/8432177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,1]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,2,1]]},"published-print":{"date-parts":[[2013,2,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.201206-029oc","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2013,2]]},"published":{"date-parts":[[2013,2,1]]}}}